Titelia

Holdings of DAFNA Capital Management LLC

69 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 57.6 % of the equity sleeve

Sector breakdown

  • Health care 1.4 %
  • Unattributed 98.6 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 94.0 %
  • GB 3.5 %
  • DK 1.3 %
  • BE 1.0 %
  • DE 0.2 %

Shares computed on the equity sleeve.

CountryLinesValueShare
US63369.2M $93.96 %
GB313.9M $3.54 %
DK15.3M $1.35 %
BE13.9M $0.99 %
DE1622.2K $0.16 %

Positions

CompanySharesValueWeight
Revolution Medicines Inc 580,67856.5M $
SPDR Series Trust 318,50540.7M $
Stereotaxis Inc 13,680,55425.2M $
Day One Biopharmaceuticals Inc 978,46321M $
AtriCure Inc 597,43117M $
Ideaya Biosciences Inc 476,74015.9M $
Cytokinetics Inc 217,49714.3M $
Compass Pathways plc 2,418,88213.4M $
Nektar Therapeutics 165,17811.9M $
iShares Biotechnology ETF 62,09510.5M $
Arcus Biosciences Inc 443,8299.6M $
Neurocrine Biosciences Inc 70,6159.3M $
Larimar Therapeutics Inc 2,029,1649.1M $
Bicara Therapeutics Inc 421,7338.4M $
Axogen Inc 249,9608.3M $
Tandem Diabetes Care Inc 355,2086.8M $
Denali Therapeutics Inc 318,5006.1M $
Century Therapeutics Inc 2,434,3535.5M $
Dexcom Inc 86,2795.4M $
KalVista Pharmaceuticals Inc 267,4025.4M $
Ascendis Pharma A/S 23,1775.3M $
MBX Biosciences Inc 175,4655.2M $
Inogen Inc 845,1795.2M $
Syndax Pharmaceuticals Inc 217,3555.1M $
Stoke Therapeutics Inc 130,8754.3M $
BioCryst Pharmaceuticals Inc 430,2484.1M $
Galapagos NV 130,1753.9M $
Immunovant Inc 150,5243.7M $
Edgewise Therapeutics Inc 112,2363.5M $
MapLight Therapeutics Inc 171,0063.5M $
Allogene Therapeutics Inc 1,370,1183.3M $
PROCEPT BIOROBOTICS CORP 120,0003M $
Align Technology Inc 15,0002.6M $
Rapport Therapeutics Inc 75,0002.3M $
Insulet Corp 10,8702.3M $
Structure Therapeutics Inc 46,5002.2M $
Celldex Therapeutics Inc 68,5182.2M $
Lexeo Therapeutics Inc 377,0592.2M $
Alector Inc 908,3512M $
Viking Therapeutics Inc 59,5161.9M $
Kura Oncology Inc 235,8681.9M $
Fulcrum Therapeutics Inc 205,0001.6M $
Aquestive Therapeutics Inc 368,4151.5M $
OrthoPediatrics Corp 95,6591.5M $
Ultragenyx Pharmaceutical Inc 61,1001.3M $
Neurogene Inc 56,6351.1M $
ARS Pharmaceuticals Inc 139,2851.1M $
CytomX Therapeutics Inc 230,0001.1M $
Maze Therapeutics Inc 35,0001M $
Mineralys Therapeutics Inc 38,4901M $
SCYNEXIS INC 1,086,956996.6K $
ORIC Pharmaceuticals Inc 98,724945.5K $
Inspire Medical Systems Inc 18,200938.8K $
TELA BIO INC 1,441,029893.4K $
ZENAS BIOPHARMA INC 42,500830.9K $
Verrica Pharmaceuticals Inc 153,712813.1K $
Fate Therapeutics Inc 550,000660K $
Annexon Inc 117,812652.7K $
Accuray Inc 1,680,508652.2K $
Adicet Bio Inc 93,812638.9K $
BioNTech SE 7,000622.2K $
Pliant Therapeutics Inc 487,000613.6K $
Orchestra BioMed Holdings Inc 126,841539.1K $
Foghorn Therapeutics Inc 111,859534.7K $
IBIO INC 193,638367.9K $
Bicycle Therapeutics PLC 64,492299.2K $
Karyopharm Therapeutics Inc 45,800255.1K $
Autolus Therapeutics PLC 179,316247.5K $
Neumora Therapeutics Inc 70,000136.5K $